284 related articles for article (PubMed ID: 12365018)
1. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
[TBL] [Abstract][Full Text] [Related]
3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
4. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
[TBL] [Abstract][Full Text] [Related]
5. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
6. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
8. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
[TBL] [Abstract][Full Text] [Related]
9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
13. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
14. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
16. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
17. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.
Cicin I; Karagol H; Uzunoglu S; Uygun K; Usta U; Kocak Z; Caloglu M; Saynak M; Tokatli F; Uzal C
Cancer; 2007 Sep; 110(5):1068-76. PubMed ID: 17614337
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for patients with spinal metastases from lung cancer.
Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
[TBL] [Abstract][Full Text] [Related]
19. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
